Patent & IP news for April 6, 2016

Patent Litigations

USPTO Weekly Stats


Patent & IP Blogs

post image Swedish Supreme Court uses three-step test to interpret restrictively freedom of panorama from

The Swedish Supreme Court
(photo courtesy of ... Wikipedia)
Earlier this week the Högsta domstolen (Swedish Supreme Court) issued a ruling that has apparently raised a good deal of attention and possibly more than an eyebrow ...

Share via E–mail | Twitter | Facebook

post image Still a few days left to respond to Public Consultation on Enforcement Directive from

Bruno doesn't have much to say,
but perhaps you do?
Looking for something to do this weekend or the next few days?

Our friends at the EU Commission wish to let IPKat readers know ...

Share via E–mail | Twitter | Facebook

post image A Theory Explaining the Evolution of U.S. Law from the Perspective of the Bio-Pharmaceutical Industry from

Why do we need a new federal law concerning trade secrecy? In a recent post on the U.S. Defend Trade Secrets Act (DTSA), I asked why are we considering the DTSA. The answer is ...

Share via E–mail | Twitter | Facebook

FDA Approves Inflectra - Celltrion's REMICADE® Biosimilar from

By Andrew Williams -- Earlier today, the U.S. Food and Drug Administration approved Celltrion's application to market Inflectra, a biosimilar to Janssen Biotech Inc.'s REMICADE (infliximab) anti-TNF-α antibody. This marks only the second ...

Share via E–mail | Twitter | Facebook

Samsung is the leading US patent leader, 24,000 ahead of IBM from

Of the top eleven active US patent holders, only four are American companies. But who gets the best return on their innovation rights is less clear.  It is no surprise that many foreign companies are ...

Share via E–mail | Twitter | Facebook

Patent for Creating and Filling Out Computerized Forms Invalid Under 35 U.S.C. § 101 from

The court granted defendant's motion to dismiss because the asserted claims of plaintiff’s patent for creating and filling out computerized forms encompassed unpatentable subject matter and found that one asserted system claim was ...

Share via E–mail | Twitter | Facebook

An Early Review of the Impact of Form 18’s Elimination on Pleading Direct Infringement from

Guest Post by Leeron Morad & Andrew J. Bramhall of Quinn Emanuel[i] Introduction On December 1, 2015, as part of a sweeping set of amendments to the Federal Rules of Civil Procedure, Rule 84 and ...

Share via E–mail | Twitter | Facebook

Alabama District Court Orders TTAB to Vacate Precedential Decision from

Last year’s Supreme Court's decision in B&B; Hardware raised the stakes in opposition proceedings when it stated that TTAB rulings may have preclusive effects in subsequent federal district court litigation. As litigants ...

Share via E–mail | Twitter | Facebook

Cardpool: Amending Claims in Reexam after Court Judgment of Invalidity from

by Dennis Crouch The timing of a settlement is sometimes really important for patentees — especially if a court is about to find your patent invalid. Slightly complex story: In Cardpool v. Plastic Jungle, the district ...

Share via E–mail | Twitter | Facebook

Odds and Ends from

Just a few odds and ends: 1)  Patently-O’s birthday is today. Can you guess how many years?  Happy Birthday, Patently-O! 2)  Those filing patent cases in Delaware in hopes of having noted patent jurist ...

Share via E–mail | Twitter | Facebook

US Senate Backs Bill Allowing Federal Courts To Handle Trade Secret Cases from

The “Defend Trade Secrets Act of 2016” cleared the Senate unanimously on 4 April. The measure amends the Economic Espionage Act of 1996 to create a private civil cause of action for trade secret misappropriation ...

Share via E–mail | Twitter | Facebook


The CAFC said:

While claims are given their broadest reasonable interpretation [BRI]
in IPR proceedings, claim interpretation still
“must be reasonable in light of the claims and specification.”
PPC Broadband, Inc. v. Corning Optical Commc ...

Share via E–mail | Twitter | Facebook

Larry Helfer on Access to Medicines from

Readers interested in the social justice concerns described in Monday's post may be interested in a book chapter that was recently posted by Professor Laurence Helfer: Pharmaceutical Patents and the Human Right to Health ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2016 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact